We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Merck & Co., Inc. stands seventh on our list and recently ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...

The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...

Merck & Co. Inc. closed 36.67% below its 52-week high of $128.73, which the company reached on July 26th.

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

Discover ServiceNow's stellar Q2 2025 results with 21.5% subscription revenue growth, expanded AI adoption, and a raised outlook.

Amphista Therapeutics has achieved a discovery research milestone in its collaboration and licence agreement with Merck. The ...

Shares of Caterpillar and Merck are trading higher Wednesday morning, lifting the Dow Jones Industrial Average into positive territory. Shares of Caterpillar and Merck have contributed to the ...

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.

Dawn Svoronos and Jane Griffiths will replace Peter Guenter and Simon Sturge, who will step down from the Board on July 28, 2025.